NU SKIN ENTERPRISES, INC. (NUS) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 256.35M USD | Liabilities, Current |
| Cash and equivalents | 189.64M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 48.90M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 191.50M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $256.35M | $189.64M | (m) | $48.90M | $191.50M | (m) |
| 2026-03-31 | (m) | $257.00M | $198.65M | (m) | $45.01M | $178.60M | (m) |
| 2025-12-31 | (m) | $263.73M | $238.63M | (m) | $39.54M | $178.64M | (m) |
| 2025-09-30 | (m) | $254.44M | $251.79M | (m) | $48.89M | $178.53M | (m) |
| 2025-06-30 | (m) | $283.91M | $264.16M | (m) | $59.70M | $180.38M | (m) |
| 2025-03-31 | (m) | $260.30M | $203.77M | (m) | $56.58M | $188.78M | (m) |
| 2024-12-31 | (m) | $296.61M | $186.88M | (m) | $50.78M | $190.24M | (m) |
| 2024-09-30 | (m) | $339.35M | $227.75M | (m) | $68.81M | $247.79M | (m) |
| 2024-06-30 | (m) | $308.59M | $224.25M | (m) | $71.55M | $243.99M | (m) |
| 2024-03-31 | (m) | $309.31M | $212.53M | (m) | $67.04M | $265.10M | (m) |
| 2023-12-31 | (m) | $328.87M | $256.06M | (m) | $72.88M | $279.98M | (m) |
| 2023-09-30 | (m) | $434.01M | $233.31M | (m) | $77.25M | $291.10M | (m) |
| 2023-06-30 | (m) | $445.04M | $235.55M | (m) | $67.17M | $372.25M | (m) |
| 2023-03-31 | (m) | $372.77M | $229.94M | (m) | $60.01M | $366.54M | (m) |
| 2022-12-31 | (m) | $359.24M | $264.73M | (m) | $47.36M | $346.18M | (m) |
| 2022-09-30 | (m) | $365.54M | $294.14M | (m) | $47.99M | $327.48M | (m) |
| 2022-06-30 | (m) | $384.14M | $363.92M | (m) | $43.69M | $354.21M | (m) |
| 2022-03-31 | (m) | $494.46M | $302.22M | (m) | $52.17M | $381.58M | (m) |
| 2021-12-31 | (m) | $529.69M | $339.59M | (m) | $41.30M | $399.93M | (m) |
| 2021-09-30 | (m) | $540.60M | $282.41M | (m) | $52.44M | $415.20M | (m) |
| 2021-06-30 | (m) | $616.30M | $354.76M | (m) | $64.70M | $390.98M | (m) |
| 2021-03-31 | (m) | $561.58M | $339.10M | (m) | $60.63M | $363.43M | (m) |
| 2020-12-31 | (m) | $542.86M | $402.68M | (m) | $63.37M | $314.37M | (m) |
| 2020-09-30 | (m) | $466.35M | $366.71M | (m) | $60.02M | $270.32M | (m) |
| 2020-06-30 | (m) | $484.63M | $375.51M | (m) | $64.37M | $261.97M | (m) |
| 2020-03-31 | (m) | $420.10M | $352.58M | (m) | $43.97M | $257.47M | (m) |
| 2019-12-31 | (m) | $356.76M | $335.63M | (m) | (m) | $275.89M | (m) |
| 2019-09-30 | (m) | $368.41M | $320.03M | (m) | (m) | $283.00M | (m) |
| 2019-06-30 | (m) | $414.55M | $360.63M | (m) | (m) | $292.70M | (m) |
| 2019-03-31 | (m) | $402.04M | $310.29M | (m) | (m) | $304.31M | (m) |
| 2018-12-31 | (m) | $439.65M | $386.91M | (m) | (m) | $295.82M | (m) |
| 2018-09-30 | (m) | $428.26M | $390.07M | (m) | (m) | $289.29M | (m) |
| 2018-06-30 | (m) | $447.05M | $402.03M | (m) | (m) | $283.73M | (m) |
| 2018-03-31 | (m) | $734.45M | $421.48M | (m) | (m) | $282.98M | (m) |
| 2017-12-31 | (m) | $447.37M | $426.40M | (m) | (m) | $253.45M | (m) |
| 2017-09-30 | (m) | $419.82M | $363.77M | (m) | (m) | $252.47M | (m) |
| 2017-06-30 | (m) | $400.50M | $345.10M | (m) | (m) | $246.66M | (m) |
| 2017-03-31 | (m) | $394.92M | $335.58M | (m) | (m) | $251.95M | (m) |
| 2016-12-31 | (m) | $399.01M | $357.25M | (m) | (m) | $249.94M | (m) |
| 2016-09-30 | (m) | $451.38M | $516.99M | (m) | (m) | $253.35M | (m) |
| 2016-06-30 | (m) | $491.11M | $544.85M | (m) | (m) | $259.93M | (m) |
| 2016-03-31 | (m) | $448.06M | $250.09M | (m) | (m) | $275.28M | (m) |
| 2015-12-31 | (m) | $407.60M | $289.35M | (m) | (m) | $265.26M | (m) |
| 2015-09-30 | (m) | $411.06M | $305.81M | (m) | (m) | $260.46M | (m) |
| 2015-06-30 | (m) | $420.75M | $292.41M | (m) | (m) | $305.03M | (m) |
| 2015-03-31 | (m) | $409.76M | $304.71M | (m) | (m) | $312.79M | (m) |
| 2014-12-31 | (m) | $418.33M | $288.42M | (m) | (m) | $338.49M | (m) |
| 2014-09-30 | (m) | $450.17M | $194.94M | (m) | (m) | $369.11M | (m) |
| 2014-06-30 | (m) | $518.68M | $219.50M | (m) | (m) | $389.65M | (m) |
| 2014-03-31 | (m) | $588.74M | $284.58M | (m) | (m) | $410.67M | (m) |
| 2013-12-31 | (m) | $776.79M | $525.15M | (m) | (m) | $339.67M | (m) |
| 2013-09-30 | (m) | $708.51M | $553.50M | (m) | (m) | $254.19M | (m) |
| 2013-06-30 | (m) | $473.63M | $402.68M | (m) | (m) | $178.18M | (m) |
| 2013-03-31 | (m) | $359.37M | $325.72M | (m) | (m) | $149.09M | (m) |
| 2012-12-31 | (m) | $320.10M | $320.02M | (m) | (m) | $135.87M | (m) |
| 2012-09-30 | (m) | $300.61M | $321.93M | (m) | (m) | $137.05M | (m) |
| 2012-06-30 | (m) | $299.08M | $371.80M | (m) | (m) | $124.68M | (m) |
| 2012-03-31 | (m) | $238.53M | $276.21M | (m) | (m) | $120.72M | (m) |
| 2011-12-31 | (m) | $241.17M | $272.97M | (m) | (m) | $112.11M | (m) |
| 2011-09-30 | (m) | $182.58M | $242.03M | (m) | (m) | $105.40M | (m) |
| 2011-06-30 | (m) | (m) | $233.40M | (m) | (m) | $108.43M | (m) |
| 2011-03-31 | (m) | $189.51M | $215.94M | (m) | (m) | $112.81M | (m) |
| 2010-12-31 | (m) | $216.45M | $230.34M | (m) | (m) | $114.47M | (m) |
| 2010-09-30 | (m) | $213.81M | $197.63M | (m) | (m) | $118.28M | (m) |
| 2010-06-30 | (m) | $190.69M | $172.67M | (m) | (m) | $113.82M | (m) |
| 2010-03-31 | (m) | (m) | $180.14M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | $185.21M | $158.04M | (m) | (m) | $105.66M | (m) |
| 2009-09-30 | (m) | (m) | $160.64M | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | $125.30M | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $114.59M | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | (m) | $87.33M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |